Physician profile
Todd L Johnson
NPI 1003850710
$2,474.89
in general payments reported to CMS, 2019-2025
18 companies · $520 in 2025
The $520 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $305 · 2020: $187 · 2021: $269 · 2022: $429 · 2023: $412 · 2024: $352 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,284.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $487.81 | 2021-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $421.75 | 2019-2025 | |
| Amgen INC. | $376.09 | 2019-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $302.80 | 2019-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $296.75 | 2021-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $175.11 | 2019-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $74.86 | 2019-2023 | Lifevest |
| Pfizer INC. | $53.95 | 2023-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $52.07 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $51.82 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $45.08 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $27.01 | 2019 | |
| Amarin Pharma, INC. | $26.60 | 2020-2021 | |
| Bridgebio Pharma, INC. | $22.19 | 2025 | Attruby |
| Philips North America LLC | $21.37 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $17.00 | 2023 | Inpefa |
| Novo Nordisk INC | $14.45 | 2025 | Wegovy |
| Z-Medica, LLC | $8.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.